Vyas Ami, Patry Emily, Owens Norma, Belviso Nicholas, Kogut Stephen J
Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, 7 Greenhouse Road, Kingston, RI, 02881, USA.
Drugs Real World Outcomes. 2019 Dec;6(4):173-181. doi: 10.1007/s40801-019-00162-x.
A majority of older adults in the United States (US) use prescription medications. Comprehensive population-level approaches to examine medication safety, effectiveness, and costs among older adults are needed.
The objectives of this study were to develop a framework of quality measures spanning the domains of safety, effectiveness, and efficiency of prescription medication use among older adults, and to apply those measures using pharmacy claims data.
We performed a retrospective study among adults age 65 years and older of a US East Coast state who filled at least one prescription from a particular pharmacy chain during 2016 (N = 99,056). Firstly, we performed an environmental scan to identify quality measures and potentially relevant measures addressing prescription medication use. These measures were reviewed and rated by local geriatric pharmacotherapy experts. After evaluating feasibility, evidence, and relevance, a total of 19 measures representing the domains of safety (n = 7), effectiveness (n = 7), and efficiency (n = 5) were identified. These measures were then applied to an older adult population using prescription data for the year 2016 provided by a national pharmacy chain. All measures were configured such that a score of 100% corresponded to optimal performance.
For the domain of safety, 12.8% of patients received a benzodiazepine chronically, 23.6% received central nervous system depressants, 16.7% received fluoroquinolones as first-line antibiotic therapy, and 21.9% of those who were prescribed opioids received them in excessive quantities. For the domain of effectiveness, one-fourth of the diabetes patients did not receive statins and angiotensin-acting medications, while 18.0% were not adherent to oral anticoagulant medications and 54% were not adherent to respiratory inhalers. For the domain of efficiency, 12.0% of the patients received prescriptions from five or more unique prescribers. Overall, 85.7%, 76.1%, and 87.9% of the older adults showed safe, effective, and efficient prescription medication use, respectively.
A novel approach to comprehensively examine the quality of medication use among older adults using prescription claims data is provided in our study. A considerable proportion of the older adults in our study received safe, effective, and efficient prescription medications. However, within each domain, several opportunities for improving the alignment of prescription medication use with current recommendations were identified.
美国大多数老年人使用处方药。需要采用全面的人群层面方法来研究老年人用药的安全性、有效性和成本。
本研究的目的是建立一个涵盖老年人处方药使用安全性、有效性和效率领域的质量指标框架,并使用药房报销数据应用这些指标。
我们对美国东海岸一个州65岁及以上的成年人进行了一项回顾性研究,这些成年人在2016年期间至少从某一特定连锁药房开具了一张处方(N = 99,056)。首先,我们进行了环境扫描,以确定质量指标和与处方药使用相关的潜在指标。这些指标由当地老年药物治疗专家进行审查和评级。在评估可行性、证据和相关性之后,共确定了19项代表安全性(n = 7)、有效性(n = 7)和效率(n = 5)领域的指标。然后,使用一家全国连锁药房提供的2016年处方数据,将这些指标应用于老年人群体。所有指标的设定方式是,100%的分数对应最佳表现。
在安全性领域,12.8%的患者长期使用苯二氮䓬类药物,23.6%的患者使用中枢神经系统抑制剂,16.7%的患者将氟喹诺酮类药物作为一线抗生素治疗,21.9%的阿片类药物处方患者过量用药。在有效性领域,四分之一的糖尿病患者未接受他汀类药物和血管紧张素作用药物,而18.0%的患者未坚持服用口服抗凝药,54%的患者未坚持使用呼吸道吸入器。在效率领域,12.0%的患者从五个或更多不同的开处方者处获得处方。总体而言,分别有85.7%、76.1%和87.9%的老年人显示出安全、有效和高效的处方药使用情况。
我们的研究提供了一种使用处方报销数据全面检查老年人用药质量的新方法。我们研究中的相当一部分老年人接受了安全、有效和高效的处方药。然而,在每个领域内,都发现了一些改善处方药使用与当前建议一致性的机会。